Drug details:
Molecular formula: C₁₇H₁₀ClN₃O₇

Standard name: 2-chloro-4-[5-[(E)-2-(4-hydroxy-5-nitro-6-oxo-1H-pyrimidin-2-yl)ethenyl]furan-2-yl]benzoic acid

Synonym:

2-chloro-4-{5-[(E)-2-(4-hydroxy-5-nitro-6-oxo-1,6-dihydropyrimidin-2-yl)ethenyl]furan-2-yl}benzoic acid

Curated SMILES: O=C(O)C1=C(Cl)C=C(C2=CC=C(/C=C/C3=NC(O)=C([N+](=O)[O-])C(=O)N3)O2)C=C1

Evidence for compound's anti-virulence activity:

Yersinia
Related VF: TTSS secreted effectors
Target: YopH
Drug effect: Protein tyrosine phatase YopH inhibitor.
Max phase: Preclinical (in vitro)
Publication:
Eriksson J, et al., 2012. Small molecule screening for inhibitors of the YopH phosphatase of Yersinia pseudotuberculosis. Adv Exp Med Biol 954:357-63.